Barbara B. Hulit
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Novanta Shares Rise Amid Positive Analyst Mentions. Recent reports highlight Novanta as a stock gaining attention from Wall Street, with one article noting its shares skyrocketed alongside other names. The company is currently trading near its 52-week low, despite analysts maintaining a higher average target price. This divergence suggests the market is currently pricing in significant caution regarding the stock's high valuation.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RBC lowers Fortive price target to $59. RBC Capital cut its price target for Fortive to $59 while maintaining a Sector Perform rating. Recent analysis suggests that while current demand remains stable, earnings growth in the second half of the year is not accelerating. This cautious outlook aligns with the stock trading near its recent support levels, reflecting a market that is waiting for clearer signs of momentum.
Transaction History
| NVST | ▲ Buy | Grant | 10,450 | $0 | 6/10/2025 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 1,217 | — | 1/2/2025 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 278 | — | 7/3/2024 | View on chart |
| NVST | ▲ Buy | Grant | 10,085 | $0 | 5/21/2024 | View on chart |
| NVST | ▲ Buy | Grant | 13,065 | $0 | 4/15/2024 | View on chart |
| NVST | ▲ Buy | Grant | 11,705 | $0 | 3/15/2024 | View on chart |
| NVST | ▲ Buy | Grant | 22,225 | $0 | 2/15/2024 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 464 | — | 1/3/2024 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 187 | — | 7/26/2023 | View on chart |
| NVST | ▲ Buy | Grant | 5,425 | $0 | 5/23/2023 | View on chart |
| NVST | ▲ Buy | Grant | 4,435 | $0 | 5/24/2022 | View on chart |
| FTV | ▲ Buy | Option Exercise | 5,400 | $168K | 11/30/2021 | View on chart |
| FTV | ▲ Buy | Option Exercise | 2,400 | $73K | 11/30/2021 | View on chart |
| FTV | ▲ Buy | Option Exercise | 2,000 | $71K | 11/30/2021 | View on chart |
| FTV | ▼ Sell | Open Market | 16,799 | $1.3M | 11/30/2021 | View on chart |
| FTV | ▲ Buy | Option Exercise | 6,999 | $173K | 11/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Piper Sandler cuts Envista price target to $26, maintains Neutral
Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.
Piper Sandler cuts Envista price target to $26, maintains Neutral. Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.